Stockholm:MNTC

Mentice AB (publ) receives an order of USD 540,000 for simulation solutions from Corewell Health, Grand Rapids, Michigan, USA

GOTHENBURG, Sweden, Dec. 30, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg , a world leader in simulation solutions for image-guided interventional therapies, announced today that Corewell Health,Grand Rapids, Michigan USA, has signed an agreement to acquire Mentice VIST® simulation solutions...

2022-12-30 20:53 3381

Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on October 26 at 10:00 CEST

GOTHENBURG, Sweden, Oct. 19, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson. To register for the presen...

2022-10-19 15:30 1437

Mentice AB (publ) receives an order of USD 620,000 for simulation solutions and development services

GOTHENBURG, Sweden, Sept. 23, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg , a world leader in simulation solutions for image-guided interventional therapies, announced today that a leading global healthcare technology company, has signed an agreement to acquire Mentice VIST® simulation solu...

2022-09-23 14:10 1748

Mentice publishes the company's interim report for the period April - June 2022

GOTHENBURG, Sweden, July 21, 2022 /PRNewswire/ -- The acquisition of Ankyras is finalized and a large order in the quarter            * The order book increased to 108.9 (67.9) MSEK and compared to 87.1 MSEK at the end of 2021. * We acquired all relevant assets relating to Ankyras from Galgo ...

2022-07-21 14:49 1584

Mentice AB (STO: MNTC) completes the acquisition of ANKYRAS

GOTHENBURG, Sweden, July 1, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) ("Mentice") Mentice today confirms the acquisition of the Ankyras business from Galgo Medical SL, as previously communicated via the press release on9th June 2022, now has been completed. The information was submitted for re...

2022-07-01 03:42 2677

Mentice receives an initial order of USD 1.93million for simulation solutions and development services from Medtronic

GOTHENBURG, Sweden, June 29, 2022 /PRNewswire/ -- Mentice, Gothenburg (STO: MNTC), a world leader in simulation solutions for image-guided interventional therapies, announced today that Medtronic,Dublin (NYSE: MDT), a global healthcare technology leader, has signed an agreement to acquire Mentice...

2022-06-29 14:37 1478

Mentice AB explores the conditions for carrying out a directed share issue of approximately SEK 60 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTOTHE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UN...

2022-06-13 15:40 1909

Mentice AB acquires all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.

STOCKHOLM, June 10, 2022 /PRNewswire/ -- In accordance with the press release published on9 June 2022, Mentice AB (publ) ("Mentice" or the "Company"), has entered into an agreement (the "Agreement") to acquire all assets relating to the software solution Ankyras ("Ankyras") from Galgo Medical S.L...

2022-06-10 04:59 2406

Mentice AB completes a directed new share issue of approximately SEK 60 million which was significantly oversubscribed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTOTHE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, CHINA HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIB...

2022-06-10 04:47 2521

Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on April 27 at 10:00 CEST

STOCKHOLM, April 20, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson. To register for the presentation o...

2022-04-20 18:28 1707

Mentice's CEO Goran Malmberg to present the company's Year-end Report Q4 2021 at a webcast conference call on February 3rd at 9:30 CET

STOCKHOLM, Jan. 27, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its year-end report via a webcast conference call with the opportunity for interested parties to ask questions to CEOGoran Malmberg and CFOGunilla Andersson. To register for the presentation o...

2022-01-27 17:42 1707

Mentice appoints Pontus Appelqvist as Vice President and GM for Asia Pacific

STOCKHOLM, April 15, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC), a leading supplier of high-tech solutions for simulation in the medical sector, with a focus on endovascular procedures, today announced the appointment of Pontus Appelqvist as Vice President and General Manager forAsia Pacific. Po...

2021-04-15 16:21 2060

Mentice to Acquire Eqip and MyIRlog™

STOCKHOLM, Oct. 9, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today signed an agreement to acquire all assets of the Jacksonville, Florida based MedTech company Eqip, Inc., a health IT cloud services and data analytics startup.   Eqip's flagship solution, MyIRlog™, is currently being used by clo...

2020-10-09 05:26 3547

Mentice to Acquire Vascular Simulations

STOCKHOLM, Oct. 2, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today signed a definitive agreement to acquire theNew York-based medical technology company Vascular Simulations (VSI), a world-leading provider of replication solutions allowing endovascular procedures to be performed by doctors mani...

2020-10-02 04:16 4237

Mentice Expands Coronary Product Portfolio with the Introduction of Coronary Intermediate Software

STOCKHOLM, March 16, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio. Coronary Intermediate follows the introduction of Coronary Essen...

2020-03-16 18:34 2342

Mentice Showcases First-of-Its-Kind Flexible Coronary Training Solution at IMSH 2020

CHICAGO, Jan. 14, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, will be showcasing the first of-its-kind flexible Coronary Essentials training solution at the 20th International Meeting on Simulation in Healthcare (IMSH 2020) inSan...

2020-01-14 03:15 1035

Mentice and Siemens Healthineers Collaborate to Perform a Live LAAC Procedure on a Virtual Patient in the Angio-suite at TCT 2019

STOCKHOLM, Sept. 24, 2019 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, is teaming with Siemens Healthineers to perform a live LAAC procedure at the Transcatheter Cardiovascular Therapeutics (TCT) 2019 symposium being held inSan Francis...

2019-09-24 00:20 1784

Mentice Introduces its Advanced, High-fidelity VIST® One TEE Echocardiography Training Solution at TCT Symposium 2019

STOCKHOLM, Sept. 16, 2019 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies will be showcasing its uniquely realistic VIST® One TEE transesophageal echocardiography simulation solution at the Transcatheter Cardiovascular Therapeutics (TCT) ...

2019-09-16 21:16 1859